Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
R. Salman (Leeds, United Kingdom), J. Robson (Leeds, United Kingdom), T. Quinn (Leeds, United Kingdom). The role of Radiological follow-up protocol in patients with surgically resected Non-Small Cell Lung Cancer.. 3023

Member's Comments

No comment yet.

Related content which might interest you: Resected Non-Small Cell Lung Cancer : A 5-year Experience Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020 Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 Prognostic role of PET/CT in surgically treated pN0-1 Non-Small-Cell Lung Cancer Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Bronchiolo-alveolar carcinoma- sometimes a difficult diagnosis Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Clinicopathological prognostic factors in operated for pulmonary carcinoid tumor patients Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Operations Which Are Technical and Difficult to Resolve in Non-Small Cell Lung Cancer: Videothoracoscopic Bi-lobectomies Source: International Congress 2017 – General thoracic surgery Year: 2017 The role of Surgical Lung Biopsy in Interstitial Lung Diseases. Is it mandatory in this time of multiple diagnostic procedures? Analysis of 186 patients surgically treated. Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Chaperone-Mediated Autophagy-Dependent Chemoresistance in Non-Small Cell Lung Cancer Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019 Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Primary lung cancer treated using radiofrequency ablation: Two year outcome data Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Outcome of patients with non specific pleuritis after medical thoracoscopy Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Radiation pneumonitis; early diagnosis and associated factors Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Prognostic and predictive value of E-cathepsin for pulmonary adenocarcinomas in the IALT (International Adjuvant Lung Cancer Trial) Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006